Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui. The most advanced program has results from a Phase 2 test in China suggesting it could be competitive with other medications that target the GLP-1 and GIP receptors to trigger weight loss. The post Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss…
To celebrate Tom Racobaldo’s upcoming retirement, Compass One Healthcare leaders who have worked closely with Tom over the years were asked to describe his impact on operations, culture and their lives. Their responses show the gratitude, respect and admiration each person has for Tom: Bobby Kutteh, CEO, Compass One Healthcare Tom has been the complete leader for our organization. His capability, steadiness, and character are unmatched. He’s a great business leader who always achieved outstanding results, but he did it by…
By MATTHEW HOLT & CLAUDE You’ll recall that a few weeks back I gave Claude some prompts and my entire corpus of work on THCB and asked it to write a piece. It was about 70% my ideas and 50% my writing tone. I’m back trying it again. This time I gave it a lot…
Over the past 15 years, financial and administrative barriers – most notably step therapy mandates and prior authorization requirements – have repeatedly forced patients through suboptimal or ineffective treatments before they can try another therapy, have tied the hands of healthcare professionals and patients alike. Now there’s a possible solution. The post Join the Fight…
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
By JEFF GOLDSMITH Healthcare payment in the US has evolved in decades-long sweeps over the past fifty years, as both public programs and employers attempted to contain the rise in health costs. Managed care in the United States has gone through three distinct phases in that time- from physician- and hospital-led HMOs to PPOs and “shadow”…
Hundreds of workers at the National Institutes of Health — the largest public funder of biomedical research in the world — are openly protesting the Trump administration’s policies regarding the agency, saying the upheaval and harm being done to the institution is so great that they felt they had no choice. A letter sent June…
AI must navigate highly sensitive, regulated and proprietary data. The big question is: How can healthcare providers securely leverage AI while maintaining trust, privacy and compliance? The post Unlocking AI’s Potential in Healthcare — A Semantic Foundation appeared first on MedCity News.
At JPM25, Nvidia announced four new partnerships focused on scaling AI models across the healthcare industry. The company is teaming up with Mayo Clinic, Illumina, IQVIA and Arc Institute. The post Nvidia Announces Partnerships with Mayo Clinic, Illumina & More at JPM25 appeared first on MedCity News.
Color Health is partnering with insurer Evry Health to offer its virtual cancer clinic to employer health plan members. The post Color Health Partners With Evry Health to Expand Access to Virtual Cancer Care appeared first on MedCity News.